EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Microbiota–Gut–Brain Axis in Disorders of Gut–Brain Interaction: Mechanisms and Emerging Therapeutic Strategies

Cong Yu iD, Xiu Wang iD, Shuzhu Chen iD

Turkish Journal of Gastroenterology · 15.09.2026

DOI: 10.5152/tjg.2026.25517 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Turkish Journal of Gastroenterology, online erschienen am 15.09.2026. Verfasst von Cong Yu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Qingdao Hospital, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital), Qingdao, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Disorders of gut–brain interaction (DGBIs), traditionally termed functional gastrointestinal disorders, affect approximately 15% of adults worldwide and are characterized by chronic digestive symptoms without identifiable structural abnormalities. According to the recently updated Rome V framework, DGBIs are characterized by pathogenic dysregulation of bidirectional communication among the central nervous system, enteric nervous system, and intestinal microbiota. This review examines the anatomical and molecular foundations of gut–brain axis (GBA) communication, emphasizing the roles of microbial metabolites (e.g., short-chain fatty acids and tryptophan derivatives) in neuroimmune modulation and visceral sensitivity. The authors analyze GBA dysfunction across major DGBIs subtypes (irritable bowel syndrome, functional dyspepsia, and functional abdominal pain syndrome), highlighting microbiota dysbiosis, barrier dysfunction, and central sensitization. Current therapies include psychological interventions, neuromodulation, microbiota-targeted approaches, dietary management, and pharmacotherapy; however, treatment responses remain highly heterogeneous across patient populations, highlighting the potential value of biomarker-guided and mechanism based therapeutic approaches. Future paradigms will require multiomics profiling, artificial intelligence, and precision medicine to develop mechanism-based diagnostics and individualized treatments, advancing care from symptom-focused to mechanism-targeted approaches. Cite this article as: Yu C, Wang X, Chen S. The microbiota–gut–brain axis in disorders of gut–brain interaction: Mechanisms and emerging therapeutic strategies. Turk J Gastroenterol. Published online September 15, 2026. doi: 10.5152/tjg.2026.25517

Schlagwörter

Stichwörter der Autor:innen

Biomarkersdisorders of gut–brain interactiongut–brain axismicrobiota–gut–brain axispersonalized medicine

Autor:innen und Institutionen

  • Department of Gastroenterology, Qingdao Hospital, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital), Qingdao, China.
  • Department of Obstetrics, Qingdao Hospital, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital), Qingdao, China.

ORCID-Profile: Cong Yu, Xiu Wang, Shuzhu Chen

Zitieren

APA

Yu, C., Wang, X., & Chen, S. (2026). The Microbiota–Gut–Brain Axis in Disorders of Gut–Brain Interaction: Mechanisms and Emerging Therapeutic Strategies. Turkish Journal of Gastroenterology. https://doi.org/10.5152/tjg.2026.25517

Vancouver

Yu C, Wang X, Chen S. The Microbiota–Gut–Brain Axis in Disorders of Gut–Brain Interaction: Mechanisms and Emerging Therapeutic Strategies. Turkish Journal of Gastroenterology. 2026. doi:10.5152/tjg.2026.25517

BibTeX
@article{Yu2026,
  author = {Yu, Cong and Wang, Xiu and Chen, Shuzhu},
  title = {The Microbiota–Gut–Brain Axis in Disorders of Gut–Brain Interaction: Mechanisms and Emerging Therapeutic Strategies},
  journal = {Turkish Journal of Gastroenterology},
  year = {2026},
  doi = {10.5152/tjg.2026.25517}
}
Kostenlos starten →